"This brief review captures the evolving role of miRNAs, focusing on their clinical relevance and implications as well as future directions for more effective targeted therapeutic interventions," write the authors.
Jane Smitham
Advertisement
Articles by Jane Smitham
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Christof Vulsteke, MD, PhD, breaks down findings, implications of KEYNOTE-905
2
The UroOnc Minute: Active Surveillance for Intermediate-risk Prostate Cancer, with Michael Leapman, MD, MHS
3
The Significance of KEYNOTE-905 in Muscle-Invasive Bladder Cancer
4
Petros Grivas, MD, on the significance of a perioperative regimen for cisplatin-ineligible MIBC
5
